These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 12926735)

  • 21. Australian Meningococcal Surveillance Programme annual report, 2015.
    Lahra MM; Enriquez RP;
    Commun Dis Intell Q Rep; 2016 Dec; 40(4):E503-E511. PubMed ID: 28043225
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Australian Meningococcal Surveillance Programme annual report, 2017.
    Lahra MM; Enriquez RP; George CRR
    Commun Dis Intell (2018); 2019 Dec; 43():. PubMed ID: 31838982
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Australian Meningococcal Surveillance Programme annual report, 2016.
    Lahra MM; Enriquez R
    Commun Dis Intell Q Rep; 2017 Dec; 41(4):E369-E382. PubMed ID: 29864389
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The changing epidemiology of meningococcal disease in the United States, 1992-1996.
    Rosenstein NE; Perkins BA; Stephens DS; Lefkowitz L; Cartter ML; Danila R; Cieslak P; Shutt KA; Popovic T; Schuchat A; Harrison LH; Reingold AL
    J Infect Dis; 1999 Dec; 180(6):1894-901. PubMed ID: 10558946
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of Neisseria meningitidis strains isolated from invasive meningococcal disease cases in Canada in 2001.
    Tsang RS; Squires SG; Tam TW
    Can J Microbiol; 2003 Oct; 49(10):633-8. PubMed ID: 14663497
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Australian Meningococcal Surveillance Programme annual report, 2019.
    Lahra MM; Hogan TR;
    Commun Dis Intell (2018); 2020 Aug; 44():. PubMed ID: 32829701
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of the epidemiological situation in invasive meningococcal disease in the Czech Republic caused by emerging Neisseria meningitidis clone ET-15/37.
    Krízová P; Musílek M; Kalmusová J
    Cent Eur J Public Health; 1997 Dec; 5(4):214-8. PubMed ID: 9457424
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Australian Meningococcal Surveillance Programme annual report, 2018.
    Lahra MM; Enriquez RP; Hogan TP;
    Commun Dis Intell (2018); 2020 Mar; 44():. PubMed ID: 32178605
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characteristics of Neisseria meningitidis isolates causing fatal disease.
    Jacobsson S; Olcén P; Löfdahl M; Fredlund H; Mölling P
    Scand J Infect Dis; 2008; 40(9):734-44. PubMed ID: 19086340
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epidemiology of invasive meningococcal disease in the Netherlands, 1960-2012: an analysis of national surveillance data.
    Bijlsma MW; Bekker V; Brouwer MC; Spanjaard L; van de Beek D; van der Ende A
    Lancet Infect Dis; 2014 Sep; 14(9):805-12. PubMed ID: 25104306
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recent epidemiological changes in meningococcal disease may be due to the displacement of serogroup A by serogroup C in Hefei City, China.
    Ni JD; Jin YH; Dai B; Wang XP; Liu DQ; Chen X; Zheng Y; Ye DQ
    Postgrad Med J; 2008 Feb; 84(988):87-92. PubMed ID: 18322129
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Meningococcal infection caused by Neisseria meningitidis serogroup C].
    Ursua MI; Rodríguez-Mayo M; Fernández-Quintairos J; Domínguez D; Luaces J; Agulla A
    Enferm Infecc Microbiol Clin; 1997; 15(7):369-72. PubMed ID: 9410050
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rise in invasive serogroup W meningococcal disease in Australia 2013-2015.
    Martin NV; Ong KS; Howden BP; Lahra MM; Lambert SB; Beard FH; Dowse GK; Saul N;
    Commun Dis Intell Q Rep; 2016 Dec; 40(4):E454-E459. PubMed ID: 28043219
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Meningococcal disease in urban south western Sydney, 1990-1994.
    Munro R; Kociuba K; Jelfs J; Brown J; Crone S; Chant K
    Aust N Z J Med; 1996 Aug; 26(4):526-32. PubMed ID: 8873936
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Have South Australian isolates of Neisseria meningitidis become less susceptible to penicillin, rifampicin and other drugs? A study of strains isolated over three decades, 1971-1999.
    Hansman D; Wati S; Lawrence A; Turnidge J
    Pathology; 2004 Apr; 36(2):160-5. PubMed ID: 15203752
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Meningococcal disease in England and Wales: 1995.
    Kaczmarski EB
    Commun Dis Rep CDR Rev; 1997 Apr; 7(4):R55-9. PubMed ID: 9127511
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Neisseria meningitidis: characterisation and epidemiology].
    Raymond J
    Arch Pediatr; 2012 Sep; 19 Suppl 2():S55-60. PubMed ID: 22883367
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in the evolution of meningococcal disease, 2001-2008, Catalonia (Spain).
    Martínez AI; Dominguez A; Oviedo M; Minguell S; Jansa JM; Codina G; Vazquez JA;
    Vaccine; 2009 May; 27(25-26):3496-8. PubMed ID: 19200816
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serogroups, serotypes, serosubtypes and antimicrobial susceptibility of Neisseria meningitidis isolates in Casablanca, Morocco.
    Zerouali K; Elmdaghri N; Boudouma M; Benbachir M
    Eur J Clin Microbiol Infect Dis; 2002 Jun; 21(6):483-5. PubMed ID: 12111610
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epidemiology of invasive meningococcal disease in France in 2003.
    Perrocheau A; Taha MK; Levy-Bruhl D
    Euro Surveill; 2005 Dec; 10(12):238-41. PubMed ID: 16371693
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.